📰 Ace2 News
Ace2 News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ace2. Real-time updates on events, politics, business and more.
December 6, 2023
Recent advances in pharmacological strategies have led to new treatments targeting the molecules responsible for inflammation.
October 4, 2023
Researchers believe inhaling so-called ACE2 proteins - found in lower levels in men with Covid - may provide a way to help protect people from Covid infection prior to entering higher-risk situations.
September 29, 2023
Researchers from the University of Texas Southwestern have developed an aerosolized, mutated form of ACE2 that effectively neutralizes various SARS-CoV-2 variants in both cell cultures and mice. The study suggests that this modified ACE2 has promising preventive and therapeutic potential against COVID-19, especially with its easy aerosolized administration.
August 29, 2023
A recent study in the Journal of Biomedical Science examines the critical role of ACE2, an enzyme involved in blood volume and electrolyte balance, in chronic diseases like cardiovascular conditions, diabetes, and COVID-19. The research suggests that ACE2 could serve as both a disease severity biomarker and a therapeutic target.
August 14, 2023
Unexpected new insights into how COVID-19 infects cells may help explain why coronaviruses are so good at jumping from species to species and will help scientists better predict how COVID-19 will evolve.
July 28, 2023
A recently developed placental organoid offers new insights into the effects of SARS-CoV-2 infection on pregnant women and their children.
July 15, 2023
The internet is ablaze with a story that claims RFK, Jr. said COVID was an ethnically targeted bioweapon that were engineered to spare Jews and Chinese people. This headline from the NY Post captures the meme that’s going wild: “RFK Jr. says COVID was ‘ethnically targeted’ to spare Jews.” The NY Post offers outstanding coverage […]
May 5, 2023
A new study investigates whether SARS-CoV-2 can enter and replicate in macrophages and whether ACE2 is involved in these mechanisms.
April 6, 2023
Researchers assessed the ability of spike proteins from 24 animal or human coronaviruses to utilize angiotensin-converting enzyme 2.
January 30, 2023
Researchers performed dSTORM (direct stochastic optical reconstruction microscopy) with several labeling techniques for visualizing and quantifying ACE2 receptor expression on various cells.